These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


678 related items for PubMed ID: 23933271

  • 1. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
    Akadam-Teker B, Kurnaz O, Coskunpinar E, Daglar-Aday A, Kucukhuseyin O, Cakmak HA, Teker E, Bugra Z, Ozturk O, Yilmaz-Aydogan H.
    Gene; 2013 Oct 10; 528(2):93-8. PubMed ID: 23933271
    [Abstract] [Full Text] [Related]

  • 2. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].
    Wang CH, Zhou X, Zhou GD, Han DF, Zheng F.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):554-8. PubMed ID: 15144588
    [Abstract] [Full Text] [Related]

  • 3. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 02; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 4. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
    Yilmaz-Aydogan H, Kurnaz O, Kucukhuseyin O, Akadam-Teker B, Kurt O, Eronat AP, Tekeli A, Bugra Z, Ozturk O.
    Gene; 2013 Jul 01; 523(1):20-6. PubMed ID: 23583468
    [Abstract] [Full Text] [Related]

  • 5. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.
    Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD.
    J Am Coll Cardiol; 2015 Apr 21; 65(15):1552-61. PubMed ID: 25770315
    [Abstract] [Full Text] [Related]

  • 6. [Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].
    Li C, Zhan Y, Li GZ, Liu SG.
    Zhonghua Fu Chan Ke Za Zhi; 2012 May 21; 47(5):342-6. PubMed ID: 22883521
    [Abstract] [Full Text] [Related]

  • 7. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ, Zhang SZ, He Y, Zhang L, Zhang KL, Huang DJ, Sun Y.
    Chin Med J (Engl); 2004 Sep 21; 117(9):1288-92. PubMed ID: 15377415
    [Abstract] [Full Text] [Related]

  • 8. Pattern of coronary artery disease risk factors in population younger than 55 years and above 55 years: a population study of 31999 healthy individuals.
    Hatmi ZN, Mahdavi-Mazdeh M, Hashemi-Nazari SS, Hajighasemi E, Nozari B, Mahdavi A.
    Acta Med Iran; 2011 Sep 21; 49(6):368-74. PubMed ID: 21874640
    [Abstract] [Full Text] [Related]

  • 9. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA, Doney AS, Dannfald J, Whitley AL, Lang CC, Morris AD, Donnan PT, Palmer CN.
    Pharmacogenet Genomics; 2008 Dec 21; 18(12):1021-6. PubMed ID: 18815589
    [Abstract] [Full Text] [Related]

  • 10. [Association of single nucleotide polymorphism in rs174570 with coronary heart diseases in Han Chinese populations].
    Li CW, Chen YC, Xiao WW, Liu R, Li X, Zeng Z.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar 21; 42(2):245-8. PubMed ID: 21500564
    [Abstract] [Full Text] [Related]

  • 11. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
    Porcellini E, Calabrese E, Guerini F, Govoni M, Chiappelli M, Tumini E, Morgan K, Chappell S, Kalsheker N, Franceschi M, Licastro F.
    Neurosci Lett; 2007 Apr 06; 416(1):66-70. PubMed ID: 17284348
    [Abstract] [Full Text] [Related]

  • 12. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT, Lindi V, Lehto S, Laakso M, Uusitupa MI.
    Mol Genet Metab; 2002 Mar 06; 75(3):260-4. PubMed ID: 11914038
    [Abstract] [Full Text] [Related]

  • 13. Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population.
    Padmaja N, Kumar RM, Balachander J, Adithan C.
    Clin Chim Acta; 2009 Apr 06; 402(1-2):139-45. PubMed ID: 19168039
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].
    Gao J, Mao YM, Cong HL, Liu Y, Zhang N, Chen Q, Liu T, Cui RZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May 06; 41(5):399-405. PubMed ID: 24021123
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M, Sertić J, Duraković Z.
    Acta Med Croatica; 2001 May 06; 55(4-5):161-7. PubMed ID: 12398019
    [Abstract] [Full Text] [Related]

  • 16. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
    Scartezini M, Hubbart C, Whittall RA, Cooper JA, Neil AH, Humphries SE.
    Clin Sci (Lond); 2007 Dec 06; 113(11):435-41. PubMed ID: 17550346
    [Abstract] [Full Text] [Related]

  • 17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 06; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 18. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y, Wang J, Bao Y, Qiao YX, Wu LZ, Li J, Li J, Hu DY.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 07; 91(21):1479-85. PubMed ID: 21914285
    [Abstract] [Full Text] [Related]

  • 19. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 07; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C, Zhou X, Ye S, Han D, Tan X, Zheng F, Shi Q.
    Int J Hyg Environ Health; 2006 May 07; 209(3):265-73. PubMed ID: 16459141
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.